Tag Archives: Funding

Spain, the European exception: ‘economic miracle’ & scientific suicide

Six years ago, the Spanish parliament approved Law 14/2011, known as the Science Law, aiming to modernise and harmonise different aspects of scientific activity in Spain, by a virtually unanimous vote. Today, Spanish scientists are still waiting for the law to be fully implemented; more than three and half years after the deadline for implementation has passed. In this article, the 5s6s Platform, a grassroots movement of Spanish scientists, including about 400 tenured scientists working in OPIs, supported by another >1300 scientists working in different Spanish Universities and other research institutions, denounces this untenable situation and requests that the Government finally implements the law. Read more [...]

Post-Brexit plans on funding and mobility

On 8th May 2017, one of the arm of the British scientific establishment, the Royal Institution, has opened its famous lecture theatre to a debate about Brexit. Brexit is not about extricating the UK from the European scientific endeavour. And Brexit does not bring to an end many important aspects of the integrated European scientific projects. Today, it is not obvious, however, which strategies the UK--and the other EU 27 countries--could adopt to sustain as much as possible international collaborations and mobility. In this opinion piece, representatives of EuroScience argue that scientists need to raise their voices to guarantee their future and the future of our societies. Should all negotiation fail and the UK ends up with weakened relations with the EU 27, the authors argue, it remains to be seen whether the UK plan to strengthen relations and collaborations with the US, the Commonwealth and East-Asia will be an adequate substitute. Read more [...]

Emmanuelle Charpentier: the strings attached to CRISPR/Cas9 success

Finding reliable funding in the course of a scientific career is difficult, even for the best scientists, says Emmanuelle Charpentier, head of regulation and infection biology at the Max-Planck-Institut in Berlin, Germany. Better known for her work on developing the CRISPR/Cas9 gene editing technique, she calls for an informed debate on the implications of her work and wishes to avoid giving into the media buzz without more in-depth reflection. In this first of a two-part series, Charpentiers shares her perspective in an authentic way. Read more [...]

Emmanuelle Charpentier: European research funding could do with less red tape

In the second instalment of a two-part series, Emmanuelle Charpentier, head of regulation and infection biology at the Max-Planck-Institut in Berlin, Germany, gives her opinion on the challenges in obtaining research funding in the current system in Europe. She also shares her views on how mobility can be hampered by bureaucracy. Finally, she points to the limited coherence for scientists pursuing a research career in Europe. Clearly, many efforts have yet to be made to improve the condition of scientists in Europe. Read more [...]

Radical funding overhaul needed to empower researchers

Funding research effectively is a demanding exercise. Young scientists gathered in Bratislava in July 2016 published a wish list for a definite overhaul of the funding system. The key to the change is to empower researchers. The proposals will be annexed to the conclusions of the EU Competitiveness Council of research and innovation ministers and tabled for adoption at the Competitiveness Council on 29 November 2016 in Brussels. Read more [...]